KMTS vs. INSP, SLNO, PRCT, NVST, LIVN, WRBY, LMAT, NVCR, ENOV, and CNMD
Should you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), LeMaitre Vascular (LMAT), NovoCure (NVCR), Enovis (ENOV), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.
Kestra Medical Technologies vs. Its Competitors
Inspire Medical Systems (NYSE:INSP) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability.
Inspire Medical Systems presently has a consensus target price of $211.91, suggesting a potential upside of 62.23%. Kestra Medical Technologies has a consensus target price of $27.50, suggesting a potential upside of 37.84%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Kestra Medical Technologies.
Inspire Medical Systems has higher revenue and earnings than Kestra Medical Technologies.
Inspire Medical Systems has a net margin of 6.67% compared to Kestra Medical Technologies' net margin of 0.00%. Inspire Medical Systems' return on equity of 8.19% beat Kestra Medical Technologies' return on equity.
Inspire Medical Systems received 193 more outperform votes than Kestra Medical Technologies when rated by MarketBeat users. However, 71.43% of users gave Kestra Medical Technologies an outperform vote while only 61.88% of users gave Inspire Medical Systems an outperform vote.
In the previous week, Inspire Medical Systems had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 5 mentions for Inspire Medical Systems and 2 mentions for Kestra Medical Technologies. Inspire Medical Systems' average media sentiment score of 1.76 beat Kestra Medical Technologies' score of 1.12 indicating that Inspire Medical Systems is being referred to more favorably in the media.
94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Inspire Medical Systems beats Kestra Medical Technologies on 11 of the 14 factors compared between the two stocks.
Get Kestra Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kestra Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:KMTS) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy KMTS Stock Free KMTS Stock Alerts